Efficacy of sifalimumab for treatment of skin injury caused by systemic lupus erythematosus

BACKGROUND: This study aims to provide the best possible evidence-based information on the efficacy and safety of sifalimumab for treatment of skin injury (SI) caused by systemic lupus erythematosus (SLE). METHODS: In this study, electronic databases of MEDLINE, EMBASE, Cochrane Library, PsycINFO, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Ai-xin, Chen, Wen-hui, Liu, Yu-hong, Gao, Peng, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824784/
https://www.ncbi.nlm.nih.gov/pubmed/31651869
http://dx.doi.org/10.1097/MD.0000000000017607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824784/
https://www.ncbi.nlm.nih.gov/pubmed/31651869
http://dx.doi.org/10.1097/MD.0000000000017607

Ejemplares similares